LIVIVO - Search results -

Search results

Result 1 - 10 of total 19

Book: Myeloma

Tanner, Jerome E.

(The biology of cancer)

2008

Author's details	Jerome Edward Tanner
Series title	The biology of cancer
Language	English
Size	119 S. : Ill.
Publisher	Chelsea House
Publishing place	New York, NY
Publishing country	United States
Document type	Book
HBZ-ID	HT016191096
ISBN	978-0-7910-8824-1 ; 0-7910-8824-3
Database	Catalogue ZB MED Medicine, Health

In stock of ZB MED Cologne/Königswinter

Shelf mark	Loan status	Location
2010 A 790	order for loan	Magazin

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: The Fatty Acid Lipid Metabolism Nexus in COVID-19.

Tanner, Jerome E / Alfieri, Caroline

Viruses

2021 Volume 13, Issue 1

Abstract: Enteric symptomology seen in early-stage severe acute respiratory syndrome (SARS)-2003 and COVID-19 is evidence of virus replication occurring in the intestine, liver and pancreas. Aberrant lipid metabolism in morbidly obese individuals adversely affects ...

Abstract	Enteric symptomology seen in early-stage severe acute respiratory syndrome (SARS)-2003 and COVID-19 is evidence of virus replication occurring in the intestine, liver and pancreas. Aberrant lipid metabolism in morbidly obese individuals adversely affects the COVID-19 immune response and increases disease severity. Such observations are in line with the importance of lipid metabolism in COVID-19, and point to the gut as a site for intervention as well as a therapeutic target in treating the disease. Formation of complex lipid membranes and palmitoylation of coronavirus proteins are essential during viral replication and assembly. Inhibition of fatty acid synthase (FASN) and restoration of lipid catabolism by activation of AMP-activated protein kinase (AMPK) impede replication of coronaviruses closely related to SARS-coronavirus-2 (CoV-2). In vitro findings and clinical data reveal that the FASN inhibitor, orlistat, and the AMPK activator, metformin, may inhibit coronavirus replication and reduce systemic inflammation to restore immune homeostasis. Such observations, along with the known mechanisms of action for these types of drugs, suggest that targeting fatty acid lipid metabolism could directly inhibit virus replication while positively impacting the patient's response to COVID-19.
MeSH term(s)	AMP-Activated Protein Kinases/metabolism ; AMP-Activated Protein Kinases/pharmacology ; Antiviral Agents/pharmacology ; Antiviral Agents/therapeutic use ; COVID-19/drug therapy ; COVID-19/metabolism ; COVID-19/virology ; Digestive System/drug effects ; Digestive System/virology ; Fatty Acid Synthases/antagonists & inhibitors ; Fatty Acid Synthases/metabolism ; Fatty Acids/metabolism ; Humans ; Lipid Metabolism ; Metformin/therapeutic use ; Obesity/drug therapy ; Obesity/metabolism ; Obesity/virology ; Orlistat/therapeutic use ; SARS-CoV-2/drug effects ; SARS-CoV-2/physiology ; Viral Proteins/metabolism ; Virus Assembly/drug effects ; Virus Replication/drug effects
Chemical Substances	Antiviral Agents ; Fatty Acids ; Viral Proteins ; Metformin (9100L32L2N) ; Orlistat (95M8R751W8) ; Fatty Acid Synthases (EC 2.3.1.85) ; AMP-Activated Protein Kinases (EC 2.7.11.31)
Language	English
Publishing date	2021-01-11
Publishing country	Switzerland
Document type	Journal Article ; Review
ZDB-ID	2516098-9
ISSN	1999-4915 ; 1999-4915
ISSN (online)	1999-4915
ISSN	1999-4915
DOI	10.3390/v13010090
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Genomic-Scale Interaction Involving Complementary Sequences in the Hepatitis C Virus 5'UTR Domain IIa and the RNA-Dependent RNA Polymerase Coding Region Promotes Efficient Virus Replication.

Rance, Elodie / Tanner, Jerome E / Alfieri, Caroline

Viruses

2018 Volume 11, Issue 1

Abstract: The hepatitis C virus (HCV) genome contains structured elements thought to play important regulatory roles in viral RNA translation and replication processes. We used in vitro RNA binding assays to map interactions involving the HCV 5'UTR and distal ... ...

Abstract	The hepatitis C virus (HCV) genome contains structured elements thought to play important regulatory roles in viral RNA translation and replication processes. We used in vitro RNA binding assays to map interactions involving the HCV 5'UTR and distal sequences in NS5B to examine their impact on viral RNA replication. The data revealed that 5'UTR nucleotides (nt) 95⁻110 in the internal ribosome entry site (IRES) domain IIa and matching nt sequence 8528⁻8543 located in the RNA-dependent RNA polymerase coding region NS5B, form a high-affinity RNA-RNA complex in vitro. This duplex is composed of both wobble and Watson-Crick base-pairings, with the latter shown to be essential to the formation of the high-affinity duplex. HCV genomic RNA constructs containing mutations in domain IIa nt 95⁻110 or within the genomic RNA location comprising nt 8528⁻8543 displayed, on average, 5-fold less intracellular HCV RNA and 6-fold less infectious progeny virus. HCV genomic constructs containing complementary mutations for IRES domain IIa nt 95⁻110 and NS5B nt 8528⁻8543 restored intracellular HCV RNA and progeny virus titers to levels obtained for parental virus RNA. We conclude that this long-range duplex interaction between the IRES domain IIa and NS5B nt 8528⁻8543 is essential for optimal virus replication.
MeSH term(s)	5' Untranslated Regions ; Cell Line, Tumor ; Genome, Viral ; Genomics ; Hepacivirus/genetics ; Hepacivirus/physiology ; Humans ; Nucleic Acid Conformation ; Open Reading Frames ; Protein Binding ; Protein Biosynthesis ; RNA Replicase/genetics ; RNA, Viral/genetics ; Virus Replication/genetics
Chemical Substances	5' Untranslated Regions ; RNA, Viral ; RNA Replicase (EC 2.7.7.48)
Language	English
Publishing date	2018-12-28
Publishing country	Switzerland
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2516098-9
ISSN	1999-4915 ; 1999-4915
ISSN (online)	1999-4915
ISSN	1999-4915
DOI	10.3390/v11010017
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture.

Tanner, Jerome E / Hu, Jing / Alfieri, Caroline

Cancers

2018 Volume 10, Issue 4

Abstract: Acute Epstein-Barr virus (EBV) infection in immunosuppressed transplant patients can give rise to a malignant B-cell proliferation known as post-transplant lymphoproliferative disease (PTLD). The EBV major virion surface glycoprotein (gp)350 is a ... ...

Abstract	Acute Epstein-Barr virus (EBV) infection in immunosuppressed transplant patients can give rise to a malignant B-cell proliferation known as post-transplant lymphoproliferative disease (PTLD). The EBV major virion surface glycoprotein (gp)350 is a principal target of naturally occurring neutralizing antibodies and is viewed as the best target to prevent acute infection and PTLD in at-risk transplant recipients. We have constructed a humanized (hu) version of the murine anti-gp350 neutralizing monoclonal antibody 72a1. The hu72a1 IgG1 antibody displayed no significant anti-mouse activity, recognized both gp350 and its splice variant gp220 as well as a gp350 peptide that was shown to constitute the principal EBV gp350 neutralizing epitope when tested in immunoassays. Hu72a1 antibody blocked in vitro EBV infection of B cells at a level which equaled that of a mouse-human chimeric 72a1 antibody construct. This work provides a further structural and immunological understanding of the 72a1 antibody interaction with EBV gp350, and constitutes a launch point for future anti-EBV therapeutic antibodies designed to block EBV infection and prevent PTLD while eliminating the deleterious antigenic murine features of the original 72a1 antibody.
Language	English
Publishing date	2018-04-09
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2527080-1
ISSN	2072-6694
ISSN	2072-6694
DOI	10.3390/cancers10040112
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Designing antibodies for oncology.

Tanner, Jerome E

Cancer metastasis reviews

2005 Volume 24, Issue 4, Page(s) 585–598

Abstract: The past five years have witnessed the emergence of monoclonal antibodies as important therapeutics for cancer treatment. Lower toxicity for antibodies versus small molecules, the potential for increased efficacy by conjugation to radioisotopes and ... ...

Abstract	The past five years have witnessed the emergence of monoclonal antibodies as important therapeutics for cancer treatment. Lower toxicity for antibodies versus small molecules, the potential for increased efficacy by conjugation to radioisotopes and cellular toxins, or the ability to exploit immune cell functions have led to clinical performances on par or superior to conventional drug therapies. This review outlines the various immunoglobulin design strategies currently available, techniques used to reduce Ig antigenicity and toxicity, and points to consider during the manufacture of antibodies for use in clinical oncology.
MeSH term(s)	Animals ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/immunology ; Antibodies, Monoclonal/pharmacology ; Drug Design ; Humans ; Neoplasms/immunology ; Neoplasms/therapy
Chemical Substances	Antibodies, Monoclonal
Language	English
Publishing date	2005-12
Publishing country	Netherlands
Document type	Journal Article ; Review
ZDB-ID	604857-2
ISSN	1573-7233 ; 0167-7659
ISSN (online)	1573-7233
ISSN	0167-7659
DOI	10.1007/s10555-005-6197-x
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1812: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article: Nucleosomes activate NF-kappaB in endothelial cells for induction of the proangiogenic cytokine IL-8.

Tanner, Jerome E

International journal of cancer

2004 Volume 112, Issue 1, Page(s) 155–160

Abstract: Solid tumors often exhibit regions undergoing apoptosis and necrosis, also referred to as "aponecrosis", juxtaposed to sites of active angiogenesis. We explored whether nucleosomes resulting from aponecrosis induced the angiogenic factor IL-8 in vascular ...

Abstract	Solid tumors often exhibit regions undergoing apoptosis and necrosis, also referred to as "aponecrosis", juxtaposed to sites of active angiogenesis. We explored whether nucleosomes resulting from aponecrosis induced the angiogenic factor IL-8 in vascular endothelial cells. Results indicate that nucleosomes induced IL-8. Nucleosomes increased IL-6 and IL-8 mRNA but not IL-10, TNF-alpha, VEGF or FGF-2 mRNA. Induction of IL-8 by nucleosomes in endothelial cells appeared to be the result of NF-kappaB/RelA transcription factor activation. The increased expression of IL-8 in vascular endothelial cells following nucleosome stimulation suggests that aponecrosis could play an important role in the promotion of tumor angiogenesis.
MeSH term(s)	Antineoplastic Agents/metabolism ; Cells, Cultured ; Endothelium, Vascular/physiology ; Fibroblast Growth Factor 2/genetics ; Fibroblast Growth Factor 2/metabolism ; Humans ; Interleukin-10/genetics ; Interleukin-10/metabolism ; Interleukin-6/genetics ; Interleukin-6/metabolism ; Interleukin-8/genetics ; Interleukin-8/metabolism ; NF-kappa B/metabolism ; Neovascularization, Physiologic ; Nucleosomes/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/metabolism ; Umbilical Veins/metabolism ; Vascular Endothelial Growth Factor A/genetics ; Vascular Endothelial Growth Factor A/metabolism
Chemical Substances	Antineoplastic Agents ; Interleukin-6 ; Interleukin-8 ; NF-kappa B ; Nucleosomes ; RNA, Messenger ; Tumor Necrosis Factor-alpha ; Vascular Endothelial Growth Factor A ; Fibroblast Growth Factor 2 (103107-01-3) ; Interleukin-10 (130068-27-8)
Language	English
Publishing date	2004-10-20
Publishing country	United States
Document type	Journal Article
ZDB-ID	218257-9
ISSN	1097-0215 ; 0020-7136
ISSN (online)	1097-0215
ISSN	0020-7136
DOI	10.1002/ijc.20390
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 478: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 576: Show issues

Order via subito

Details ▾

Article: Whole genome sequence analysis of apparent treatment resistant hypertension status in participants from the Trans-Omics for Precision Medicine program.

Armstrong, Nicole D / Srinivasasainagendra, Vinodh / Ammous, Farah / Assimes, Themistocles L / Beitelshees, Amber L / Brody, Jennifer / Cade, Brian E / Ida Chen, Yii-Der / Chen, Han / de Vries, Paul S / Floyd, James S / Franceschini, Nora / Guo, Xiuqing / Hellwege, Jacklyn N / House, John S / Hwu, Chii-Min / Kardia, Sharon L R / Lange, Ethan M / Lange, Leslie A /

McDonough, Caitrin W / Montasser, May E / O'Connell, Jeffrey R / Shuey, Megan M / Sun, Xiao / Tanner, Rikki M / Wang, Zhe / Zhao, Wei / Carson, April P / Edwards, Todd L / Kelly, Tanika N / Kenny, Eimear E / Kooperberg, Charles / Loos, Ruth J F / Morrison, Alanna C / Motsinger-Reif, Alison / Psaty, Bruce M / Rao, Dabeeru C / Redline, Susan / Rich, Stephen S / Rotter, Jerome I / Smith, Jennifer A / Smith, Albert V / Irvin, Marguerite R / Arnett, Donna K

Frontiers in genetics

2023 Volume 14, Page(s) 1278215

Abstract: Introduction: ...

Abstract	Introduction:
Language	English
Publishing date	2023-12-13
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2606823-0
ISSN	1664-8021
ISSN	1664-8021
DOI	10.3389/fgene.2023.1278215
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Transfusion-related Epstein-Barr virus (EBV) infection: A multicenter prospective cohort study among pediatric recipients of hematopoietic stem cell transplants (TREASuRE study).

Enok Bonong, Pascal R / Buteau, Chantal / Delage, Gilles / Tanner, Jerome E / Lacroix, Jacques / Duval, Michel / Laporte, Louise / Tucci, Marisa / Robitaille, Nancy / Spinella, Philip C / Cuvelier, Geoffrey / Vercauteren, Suzanne / Lewis, Victor / Fearon, Margaret / Drews, Steven J / Alfieri, Carolina / Trottier, Helen

Transfusion

2020 Volume 61, Issue 1, Page(s) 144–158

Abstract: Background: Epstein-Barr virus (EBV) is carried in the blood of most adults, and transfusion-related infections have been reported. EBV is particularly deleterious in immunosuppressed transplant patients. The aim was to determine if EBV transmission ... ...

Abstract	Background: Epstein-Barr virus (EBV) is carried in the blood of most adults, and transfusion-related infections have been reported. EBV is particularly deleterious in immunosuppressed transplant patients. The aim was to determine if EBV transmission occurred through leukodepleted blood product transfusion in pediatric recipients of hematopoietic stem cell transplants (HSCT). Study design and methods: This prospective Canadian multi-center cohort study includes 156 allogeneic HSCT pediatric recipients. The association between EBV and transfusion was analyzed using Cox regressions. EBV infection, defined by a PCR+ test in the blood of seronegative recipients of an EBV-negative graft, was monitored in order to correlate the recipient EBV strain with that of the blood donors. EBV genotypes were determined by PCR amplification followed by DNA sequencing at two loci (EBNA3b and LMP1). Results: No statistically significant associations were found between transfusions and EBV. One case of post-transplant EBV infection was identified among the 21 EBV-seronegative recipients receiving an EBV-negative graft. A total of 22 blood donors were retraced to determine whether the recipient's EBV strain matched that of a donor. One donor strain showed 100% sequence homology at the EBNA3b locus, but differed by one or two point mutations and by a 132-bp deletion at the LMP1 locus. The blood donor in question was alone among the 22 donors to show amplifiable virus in plasma. Blood from this donor readily produced an immortalized lymphoblastoid cell line in culture. Conclusion: While considered a rare event, EBV transmission through transfusion may occur in the context of severe immunosuppression.
MeSH term(s)	Blood Donors/statistics & numerical data ; Blood Transfusion/methods ; Blood Transfusion/statistics & numerical data ; Canada/epidemiology ; Child ; Child, Preschool ; Cohort Studies ; Epstein-Barr Virus Infections/diagnosis ; Epstein-Barr Virus Infections/transmission ; Epstein-Barr Virus Infections/virology ; Epstein-Barr Virus Nuclear Antigens/genetics ; Female ; Genotype ; Hematopoietic Stem Cell Transplantation/adverse effects ; Herpesvirus 4, Human/genetics ; Herpesvirus 4, Human/immunology ; Humans ; Immunosuppression/adverse effects ; Male ; Prospective Studies ; Transfusion Reaction/virology ; Transplant Recipients/statistics & numerical data ; Viral Matrix Proteins/genetics
Chemical Substances	EBNA-3B antigen ; EBV-associated membrane antigen, Epstein-Barr virus ; Epstein-Barr Virus Nuclear Antigens ; Viral Matrix Proteins
Language	English
Publishing date	2020-10-22
Publishing country	United States
Document type	Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
ZDB-ID	208417-x
ISSN	1537-2995 ; 0041-1132
ISSN (online)	1537-2995
ISSN	0041-1132
DOI	10.1111/trf.16149
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 284: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Adaptively introgressed Neandertal haplotype at the OAS locus functionally impacts innate immune responses in humans.

Sams, Aaron J / Dumaine, Anne / Nédélec, Yohann / Yotova, Vania / Alfieri, Carolina / Tanner, Jerome E / Messer, Philipp W / Barreiro, Luis B

Genome biology

2016 Volume 17, Issue 1, Page(s) 246

Abstract: Background: The 2'-5' oligoadenylate synthetase (OAS) locus encodes for three OAS enzymes (OAS1-3) involved in innate immune response. This region harbors high amounts of Neandertal ancestry in non-African populations; yet, strong evidence of positive ... ...

Abstract	Background: The 2'-5' oligoadenylate synthetase (OAS) locus encodes for three OAS enzymes (OAS1-3) involved in innate immune response. This region harbors high amounts of Neandertal ancestry in non-African populations; yet, strong evidence of positive selection in the OAS region is still lacking. Results: Here we used a broad array of selection tests in concert with neutral coalescent simulations to demonstrate a signal of adaptive introgression at the OAS locus. Furthermore, we characterized the functional consequences of the Neandertal haplotype in the transcriptional regulation of OAS genes at baseline and infected conditions. We found that cells from people with the Neandertal-like haplotype express lower levels of OAS3 upon infection, as well as distinct isoforms of OAS1 and OAS2. Conclusions: We present evidence that a Neandertal haplotype at the OAS locus was subjected to positive selection in the human population. This haplotype is significantly associated with functional consequences at the level of transcriptional regulation of innate immune responses. Notably, we suggest that the Neandertal-introgressed haplotype likely reintroduced an ancestral splice variant of OAS1 encoding a more active protein, suggesting that adaptive introgression occurred as a means to resurrect adaptive variation that had been lost outside Africa.
MeSH term(s)	2',5'-Oligoadenylate Synthetase/genetics ; Animals ; Evolution, Molecular ; Gene Expression Regulation, Enzymologic ; Genome, Human ; Haplotypes/genetics ; Humans ; Immunity, Innate/genetics ; Infections/genetics ; Infections/immunology ; Infections/pathology ; Neanderthals/genetics ; Neanderthals/immunology ; Polymorphism, Single Nucleotide ; Protein Isoforms/genetics ; Protein Isoforms/immunology ; Selection, Genetic/genetics ; Selection, Genetic/immunology
Chemical Substances	Protein Isoforms ; OAS1 protein, human (EC 2.7.7.-) ; OAS2 protein, human (EC 2.7.7.-) ; 2',5'-Oligoadenylate Synthetase (EC 2.7.7.84) ; OAS3 protein, human (EC 2.7.7.84)
Language	English
Publishing date	2016-11-29
Publishing country	England
Document type	Journal Article
ZDB-ID	2040529-7
ISSN	1474-760X ; 1474-760X
ISSN (online)	1474-760X
ISSN	1474-760X
DOI	10.1186/s13059-016-1098-6
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article: Reduction in intracellular HCV RNA and virus protein expression in human hepatoma cells following treatment with 2'-O-methyl-modified anti-core deoxyribozyme.

Trepanier, Janie B / Tanner, Jerome E / Alfieri, Caroline

Virology

2008 Volume 377, Issue 2, Page(s) 339–344

Abstract: HCV RNA is gaining greater consideration as a principal target for newer HCV antivirals because its destruction has the potential of eliminating the virus. These newer antivirals include deoxyribozymes (Dz), which are small single-stranded DNA molecules ... ...

Abstract	HCV RNA is gaining greater consideration as a principal target for newer HCV antivirals because its destruction has the potential of eliminating the virus. These newer antivirals include deoxyribozymes (Dz), which are small single-stranded DNA molecules that cleave homologous RNA targets. Using a liver cell model containing functional genomic-length HCV-1b RNA we tested whether 2'-O-methyl-modified Dz, designed to recognize a highly-conserved RNA sequence located within the core-E1 coding region, could recognize and cleave its target sequence in the structural context of a functional HCV RNA molecule. Dz858-4-OMe contains four 2'-O-methyl nucleotide derivatives consecutively located on the distal ends of its two annealing arms. Intracellular HCV RNA, core protein and HCV antigen expression were reduced by 63%, 87% and 84%, respectively, when HCV RNA was challenged 6 h post-transfection with Dz858-4-OMe. The observed reduction of intracellular HCV RNA and protein by Dz858-4-OMe suggests that it may constitute an attractive HCV antiviral.
MeSH term(s)	Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/virology ; DNA, Catalytic/genetics ; DNA, Catalytic/pharmacology ; Gene Expression Regulation, Viral/drug effects ; Hepacivirus/drug effects ; Hepacivirus/genetics ; Hepacivirus/metabolism ; Humans ; RNA, Viral/drug effects ; RNA, Viral/genetics ; RNA, Viral/metabolism ; Viral Proteins/drug effects ; Viral Proteins/metabolism
Chemical Substances	DNA, Catalytic ; RNA, Viral ; Viral Proteins
Language	English
Publishing date	2008-08-01
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	200425-2
ISSN	1096-0341 ; 0042-6822
ISSN (online)	1096-0341
ISSN	0042-6822
DOI	10.1016/j.virol.2008.04.022
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Ud II Zs.172: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito